| 000 | 01609 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513171018.0 | ||
| 264 | 0 | _c19990413 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a0021-972X | ||
| 024 | 7 |
_a10.1210/jcem.84.3.5539 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLewis, G F | |
| 245 | 0 | 0 |
_aCounterregulatory response to hypoglycemia differs according to the insulin delivery route, but does not affect glucose production in normal humans. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cMar 1999 |
||
| 300 |
_a1037-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aC-Peptide _xblood |
| 650 | 0 | 4 |
_aFatty Acids, Nonesterified _xblood |
| 650 | 0 | 4 |
_aGlucose _xadministration & dosage |
| 650 | 0 | 4 |
_aHormones _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperinsulinism _xchemically induced |
| 650 | 0 | 4 |
_aHypoglycemia _xblood |
| 650 | 0 | 4 | _aHypoglycemic Agents |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 |
_aLactic Acid _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPortal Vein |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aTolbutamide |
| 650 | 0 | 4 | _aVeins |
| 700 | 1 | _aCarpentier, A | |
| 700 | 1 | _aBilinski, D | |
| 700 | 1 | _aGiacca, A | |
| 700 | 1 | _aVranic, M | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 84 _gno. 3 _gp. 1037-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jcem.84.3.5539 _zAvailable from publisher's website |
| 999 |
_c10044370 _d10044370 |
||